Korro Bio, Inc.

Korro Bio, Inc. financial statements

Korro Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 6.39M10-K
Net income−USD 117.26M10-K
Cash and equivalentsUSD 21.82M10-Q
Total debtUSD 43.49MEODHD

Korro Bio, Inc. financials on 6ix · Korro Bio, Inc. on 6ix